East Resources Acquisition Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ERES research report →
Price Chart
About the company
East Resources Acquisition Company is not currently engaged in any significant operational activities. Its primary objective is to complete a business combination, such as a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization, with one or more existing enterprises. The firm intends to identify prospective opportunities within the North American energy sector.
- CEO
- Terrence M. Pegula
- IPO
- 2023
- Employees
- 82
- HQ
- Boca Raton, FL, US
Get TickerSpark's AI analysis on ERES
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $124.57M
- P/E
- 18.04
- PEG
- 0.06
- P/S
- 2.31
- P/B
- 1.43
- EV/EBITDA
- 8.91
- Div Yield
- 3.01%
- Gross Margin
- 70.06%
- Op Margin
- 30.81%
- Net Margin
- 12.67%
- ROE
- 8.21%
- ROIC
- 6.23%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0-100.0%
- Op Income
- $88.76M
- Net Income
- $36.53M+0.0%
- EPS
- $0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $11.27
- 52W Low
- $7.17
- 50D MA
- $8.97
- 200D MA
- $8.97
- Beta
- -0.02
- RSI (14)
- 57
- Avg Volume
- 120.17K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Abacus delivered a strong Q3 with revenue and profitability growth, raised full-year guidance, and highlighted major progress in LifeARC, fund inflows, and its first large securitization platform.· November 5, 2026
- Q3 revenue was $76.9 million, up 22% year over year; adjusted EBITDA was $42.3 million with a 55% margin, and adjusted EPS was $0.29.
- The company raised full-year 2026 guidance to adjusted net income of $104.5 million to $106.5 million and adjusted EPS of $1.05 to $1.07, after Q3 adjusted net income of $29.4 million beat guidance.
- Longevity fund inflows reached about $452.4 million in Q3, and year-to-date longevity fund inflows were $997 million versus $604 million for all of 2025.
- Abacus closed its largest securitization to date, a more than $400 million structure that was 2x oversubscribed and is expected to support 2 to 3 securitizations per year.
- LifeARC early traction looked strong, with 357 inquiries to date, over $500 million in investable assets in the pipeline, and management emphasizing new partnerships with Retirable and Manning & Napier.
Abacus reported third-quarter revenue of $76.9 million, up 22% year over year. Life Solutions revenue was $71.3 million, up 32% from $54.1 million a year ago, while Technology Services revenue was $0.6 million, up 155% from $0.2 million. Adjusted EBITDA was $42.3 million, up 12% year over year, with a 55% margin; adjusted net income was $29.4 million, and adjusted EPS was $0.29. Operating expenses were $43.4 million, and adjusted return on equity was 26%, up 440 basis points year over year. Cash at quarter-end was $104 million, policy assets were $370 million, and long-term debt excluding nonrecourse liabilities was $366 million. On the balance sheet, annualized portfolio turnover was 3x, average realized gain on policy sales was about 24%, and capital deployed in the quarter was $235.3 million. Management raised full-year 2026 guidance to adjusted net income of $104.5 million to $106.5 million and adjusted EPS of $1.05 to $1.07. For Q4, it expects adjusted net income of $28 million to $30 million and adjusted EPS of $0.28 to $0.30. The board also approved a 10% increase in the regular annual dividend to $0.22 per share, and the company bought back $1.7 million of stock at an average price of $8.13.
Jay Jackson’s message was that Abacus is entering a more visible and scalable phase, with LifeARC as the centerpiece of the long-term story. He framed the quarter as proof that the company can combine longevity data, institutional capital markets, and consumer-facing planning tools, while also stressing validation from fund inflows and the oversubscribed securitization. His tone was upbeat and confident, but he also repeatedly tied that optimism to concrete proof points rather than abstract promises.
Bill McCauley focused on the quarter’s financial outperformance and the tightening connection between earnings and cash. He highlighted that Q3 adjusted net income of $29.4 million beat prior guidance, leading to higher full-year guidance of $104.5 million to $106.5 million and Q4 guidance of $28 million to $30 million. He also pointed to strong cash conversion, saying year-to-date operating cash flow was $1.46 for every dollar of adjusted EBITDA, while cash ended at $104 million and long-term debt excluding nonrecourse liabilities was $366 million. On capital returns, he noted the $100 million buyback authorization, the $1.7 million repurchase in the quarter, and the board’s 10% dividend increase to $0.22 per share.
Analysts focused on the policy and growth implications of the business: one asked whether changes in Washington could affect the company, and Jay Jackson said a lower estate tax threshold could actually increase demand for life insurance policies, while broader regulation looked manageable regardless of party. Questions also centered on distribution for the ABX fund, where management said platform rollout is progressing and that meaningful flows should begin in Q1. Other analysts asked about the decline in fee-related AUM revenue, and management attributed it to one-time adjustments tied to closed-end and offshore funds, while expecting the trend to reverse in Q4 and Q1. The call also covered debt, buybacks, securitization economics, and the Manning & Napier and Retirable partnerships; management said debt would be handled opportunistically, securitization earnings would not be separately disclosed, and both partnerships are already generating visible activity across sourcing, advisory leads, and fund distribution.
The quarter showed multiple signs that Abacus’s model is scaling: revenue, EBITDA, adjusted net income, and cash conversion all improved, while guidance moved higher again. Management sees a growing mix shift toward fee-related revenues from funds and securitizations, and early LifeARC traction plus the large securitization suggest more channels for monetizing the same origination platform.
A lot of the story still depends on early-stage products and future execution, especially LifeARC, which is still generating inquiries rather than meaningful revenue. Some fee-related AUM revenue was lower quarter-over-quarter due to one-time adjustments, and management acknowledged that capital deployed and securitization size will not grow at the same pace forever. The company also remains exposed to rate, funding, and portfolio-construction dynamics, including how future securitizations are sized and how debt is managed when notes become callable in 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 549.8%
- Shares Outstanding
- 11.48M
- Float Shares
- 63.12M
of shares held by institutions
12 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Omni Partners Us LLC | 352.39K | ▲ 11.59K |
| Omni Partners Llp | 313.96K | ▼ 168.41K |
| Seaport Global Asset Management LLC | 1.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 23 | Gusky Adam Samuel | buy | 5,000 |
| Nov 16, 23 | Gusky Adam Samuel | buy | 7,200 |
| Nov 9, 23 | Gusky Adam Samuel | other | 7,500 |
| Nov 9, 23 | Schulte Mary Beth | other | 9,000 |
| Nov 9, 23 | van Katwijk Cornelis Michiel | other | 7,500 |
| Nov 9, 23 | Corbett Thomas Wingett JR | other | 7,500 |
| Nov 9, 23 | Radka Karla | other | 7,500 |
| Oct 27, 23 | McCauley William Hugh JR | other | 500,000 |
| Oct 13, 23 | Pegula Terrence M. | other | 2,802,000 |
| Oct 13, 23 | McNealy Sean | sell | 700,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ERES coverage
Recent articles, reports, and earnings notes.
No research on ERES yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ERES report →